Macular disease - AMD

UNSW Sydney has established the Shirley and John Sarks Chair in Age-related Macular Degeneration after receiving a $10.8 million philanthropic...

Geographic atrophy (GA) continues to present significant challenges in both diagnosis and long-term patient management, as emerging therapies and evolving...

A recent study suggests that levodopa, a common Parkinson’s disease medication, may reduce the risk of progression from early-stage age-related...

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

Ikarovec Limited,a UK-based company pioneering dual-pathway gene therapies for retinal diseases, has entered into an exclusive agreement with VectorBuilder to...

Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of...

Eyecare practitioners are being advised to prepare for potential disruption to patient billing pathways, with the federal government considering changes...

Australia now has two treatments for geographic atrophy (GA) after the Therapeutic Goods Administration (TGA) approved a second medication. It...

A landmark international clinical trial has demonstrated the potential of a subretinal photovoltaic implant to restore central vision in patients...

Two of Australia’s leading experts in macular research – Professor Robyn Guymer AM and Associate Professor Zhichao Wu from the...